Phase I/II Study of Carfilzomib in Combination With Bendamustine and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Phase of Trial: Phase I/II
Latest Information Update: 05 Feb 2018
At a glance
- Drugs Carfilzomib (Primary) ; Bendamustine; Dexamethasone; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions
- 30 Jan 2018 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2018.
- 12 Dec 2017 Preliminary results (n=15) presented at the 59th Annual Meeting and Exposition of the American Society of Hematology
- 12 Jan 2017 Planned End Date changed from 1 Nov 2017 to 1 Nov 2018.